Peter Libby, MD, to keynote annual CMHC, with focus on revolutionizing atherosclerosis care
Click Here to Manage Email Alerts
Key takeaways:
- The annual Cardiometabolic Health Congress will be held in October in Boston.
- Attendees will hear the latest on trending topics in cardiorenal and cardiometabolic health.
The Cardiometabolic Health Congress announced that Peter Libby, MD, one of the foremost authorities in atherosclerosis, will deliver the keynote address at its upcoming 19th annual conference.
The CMHC conference — Decoding the Constellation of Cardiometabolic Health and Risk Factors — will be held Oct. 17 to 19 at the Boston Park Plaza.
Insights from a leading expert in atherosclerosis
Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medicine School. A world-renowned author and lecturer on cardiovascular medicine and atherosclerosis, Libby has been published extensively in leading medical journals. He led the pivotal CANTOS trial, which clinically validated the role of inflammation in atherosclerosis. Libby has been awarded the 2024 Valentin Fuster Award for Innovation in Science for his leadership and innovative work in this field, according to a CMHC press release.
Libby’s keynote, “Prevention and Treatment of Atherosclerosis,” will provide an update on his research on inflammation and atherosclerosis. He will also present practical approaches for targeting and treating inflammation in everyday clinical practice.
“It is gratifying to have the work we started on inflammation and immunity in atherosclerosis so many years ago being recognized and becoming actionable for our patients,” Libby said.
Libby acknowledges significant strides in treating individual cardiometabolic conditions. However, cardiovascular disease, diabetes, kidney disease and liver disease remain among the most pervasive chronic conditions in the United States.
His keynote address will set the tone for the conference, where attendees will explore how diseases across the cardiometabolic spectrum share common roots and affect related organs, increasing overall systemic stress. It will specifically underscore that a single cardiometabolic condition raises the risk of others and the likelihood of poor health outcomes.
About the 19th annual CMHC
As “The Cardiometabolic Event of the Year,” Decoding the Constellation of Cardiometabolic Health and Risk Factors will focus on critical clinical considerations and trending topics in cardiorenal and cardiometabolic health. This year’s conference will particularly address the overlapping, interconnected constellations of cardiometabolic conditions that challenge current care models.
The medical education conference will span 3 days and feature:
- didactic lectures;
- expert panel debates;
- real-patient case discussions;
- prize giveaways;
- professional development opportunities; and
- industry access and networking.
Healio is an official media partner of CMHC. The Healio team will provide live coverage from the meeting, including reports on the sessions above and more.
For more information:
To register for the 19th annual CMHC, visit www.cardiometabolichealth.org/19th-annual-cmhc/.
Collapse
Read more about
Click Here to Manage Email Alerts